FdaApplication
ANDA 218002
Identifiers
- fda_app_no: ANDA218002
Properties
| Property | Value |
|---|---|
| applicant_name | INGENUS PHARMACEUTICALS LLC |
| application_type | ANDA |
| approval_date | 2024-04-05 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| TAFLUPROST | TAFLUPROST | 0.0015% | SOLUTION/DROPS;OPHTHALMIC |
1 product